Nektar Therapeutics Announces Pricing of Upsized $400 Million Public Offering ...Middle East

SAN FRANCISCO, Feb. 11, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced the pricing of its upsized underwritten public offering of $400 million...

Hence then, the article about nektar therapeutics announces pricing of upsized 400 million public offering was published today ( Thursday 12/02/2026 - 06:30 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nektar Therapeutics Announces Pricing of Upsized $400 Million Public Offering )

Also on site :

• AI companies are building huge natural gas plants to power data centers. What could go wrong?
• Europe’s cyber agency blames hacking gangs for massive data breach and leak
• The Trump Dictatorship Is Cracking Up